Hope in Huntington's disease: A survey in counseling patients with Huntington's disease, as well as the caregivers

Neural Regeneration Research

Volumn 4, Issue 9, 2009, Pages 717-720

  Marcinkowski, Jerzy T ^a   Zielonka, Daniel ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Huntington's disease; Patient hope; REGISTRY project

Indexed keywords

ADOLESCENT; ADULT; AGED; CAREGIVER; CHILD; CLINICAL ARTICLE; FEMALE; GENE; GENE MUTATION; HEALTH SURVEY; HOPE; HUMAN; HUNTINGTON CHOREA; INTERVIEW; IT15 GENE; MALE; PATIENT COUNSELING; PATIENT PARTICIPATION; REVIEW; SCHOOL CHILD;

EID: 70350741283     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2009.09.014     Document Type: Review

References (24)

1. Meder J. Interview of Agnieszka Katrynicz with president of Union of Polish Oncologists and head of Department of Lymphatic System Neoplasm from Oncology Center Warsaw. Gazeta Lekarska. 2008;07/08.
2. Majewicz A. GP's role and possibilities in enforcing circulatory system diseases prevention programs in small towns and villages - case of Zbaszyn commune. Poznan: Poznan University of Medical Sciences. 2008.
3. Mende-Mueller LM, Toneff T, Hwang SR, et al. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J Neurosci. 2001;21(6):1830-1837. (Pubitemid 32221366)
4. Kuran W, Rzeski M, Rakowicz M, et al. Dopaminergic treatment of Westphal form of Huntington's disease-case report. Neurol Neurochir Pol. 2000;Supl. 5:14.
5. Sánchez A, Milà M, Castellví-Bel S, et al. Molecular analysis of the IT15 gene in 79 Spanish families with Huntington's disease: diagnostic confirmation and presymptomatic diagnosis. Med Clin (Barc). 1997;108(18):687-690. (Pubitemid 127522655)
6. Ho LW, Carmichael J, Swartz J, et al. The molecular biology of Huntington's disease. Psychol Med. 2001;31(1):3-14.
7. Sánchez-Pernaute R, Künig G, del Barrio Alba A, et al. Bradykinesia in early Huntington's disease. Neurology. 2000;54(1):119-125.
8. Louis ED, Anderson KE, Moskowitz C, et al. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Arch Neurol. 2000;57(9):1326-1330. (Pubitemid 30695807)
9. Pekmezovic T, Svetel M, Maric J, et al. Survival of Huntington's disease patients in Serbia: longer survival in female patients. Eur J Epidemiol. 2007;22(8):523-526. (Pubitemid 47222949)
10. Landwehrmeyer GB, Dubois B, de Yébenes JG, et al. Riluzole in Huntington's disease: a 3-year, randomized controlled study. Ann Neurol. 2007;62(3):262-272. (Pubitemid 47525402)
11. Solomon AC, Stout JC, Weaver M, et al. Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord. 2008;23(13):1830-1836.
12. Ivanova-Smolenskaia IA, Ovchinnikov IV, Illarioshkin SN, et al. Molecular genetic testing in the diagnosis of sporadic cases of Huntington's chorea. Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98(3):19-22.
13. Gargiulo M, Lejeune S, Tanguy ML, et al. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet. 2009;17(2):165-171.
14. Licklederer C, Wolff G, Barth J. Mental health and quality of life after genetic testing for Huntington disease: a long-term effect study in Germany. Am J Med Genet A. 2008;146A(16):2078-2085.
15. Bondor B, Kárteszi J, Hadzsiev K, et al. Psychological aspects of presymptomatic diagnosis in Huntington disease. Orv Hetil. 2008;149(13):609-612.
16. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 59th WMA General Assembly, Seoul, October 2008.
17. Puri KS, Suresh KR, Gogtay NJ, et al. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 2009;55(2):131-134.
18. Boyce C, Neale P. Conducting In-Depth Interviews: A Guide for Designing and Conducting In-Depth Interviews for Evaluation Input in Monitoring and Evaluation - 2. Pathfinder International, May 2006.
19. European Huntington's Disease Network. Registry research project. http://www.euro-hd.net/html/registry/about.
20. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971-983.
21. Reuter I, Tai YF, Pavese N et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry. 2008;79(8):948-951.
22. Bonelli RM, Mahnert FA, Niederwieser G. Olanzapine for Huntington's disease: an open label study. Clin Neuropharmacol. 2002;25(5):263-265. (Pubitemid 35239484)
23. Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology. 2006;66(3):366-372. (Pubitemid 43739938)
24. Aymé S, Schmidtke J. Networking for rare diseases: a necessity for Europe. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(12):1477-1483.